Licoisoflavone A, CAS [[66056-19-7]]

Produktübersicht

• Artikelname: Licoisoflavone A, CAS [[66056-19-7]]
• Artikelnummer: MCE-HY-N3389
• Hersteller Artikelnummer: HY-N3389
• Alternativnummer: MCE-HY-N3389-5MG,MCE-HY-N3389-10MG,MCE-HY-N3389-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Licoisoflavone A is an orally active isoflavone. Licoisoflavone A inhibits proliferation, induces apoptosis, and causes G1/S phase arrest in colorectal cancer (CRC) cells. Licoisoflavone A inhibits the CDK2-Cyclin E1 axis. Licoisoflavone A inhibits lipid peroxidation with an IC50 of 7.2 µM. Licoisoflavone A shows a dose-dependent inhibition effect on SARS-CoV-2 infection. Licoisoflavone A exhibits significant anti-tumor efficacy in mice bearing CT26 cell subcutaneous xenografts. Licoisoflavone A can be used for the study of colorectal cancer and SARS-CoV-2 infection[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 354.35
• Reinheit: 99.41
• CAS Nummer: [66056-19-7]
• Formel: C20H18O6
• Target-Kategorie: Apoptosis,CDK,SARS-CoV,Sirtuin

Anwendungsbeschreibung

• Anwendungsbeschreibung: Natural Products